MARKUS BYRON: Open Payments
NPI 1013678010 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 56 payments from 16 companies in 2025. Trend: 2023 $2,540 · 2024 $625 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 21 | $214 |
| Procept Biorobotics Corporation | 2 | $110 |
| Antares Pharma, Inc. | 6 | $106 |
| Janssen Biotech, Inc. | 2 | $102 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $82 |
| UROGEN PHARMA, INC. | 4 | $77 |
| COLOPLAST CORP | 3 | $57 |
| ABBVIE INC. | 2 | $53 |
| Olympus America Inc. | 3 | $51 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $45 |
Products named: GEMTESA, AQUABEAM ROBOTIC SYSTEM, XYOSTED, JOURNAVX, RYBREVANT, BOTOX, iTIND System, Personal Catheter Intermittent Catheter.
Industry payments across MI — which companies pay providers there.
